Access to Vaccines Index 2017

The Index finds a high level of diversity in how vaccine companies are improving access to vaccines for people living in poorer countries. GSK leads the three areas evaluated, with a strong performance from Sanofi across the board…

News

13 Feb 2018

Vaccine companies have released 18 statements about their vaccines businesses since the first Access to Vaccines Index was published in March 2017. The Access to Medicine Foundation has reviewed these statements to give a sense of the level of momentum in the vaccines industry to improve access to vaccines.

06 Mar 2017

The first Access to Vaccines Index will be published on Monday 6 March, 2017. It is the first tool of its kind to present the current landscape of vaccine company behaviour when it comes to making vaccines more accessible for the populations that need them.

06 Mar 2017

On Wednesday 31 May, the Interfaith Center on Corporate Responsibility (ICCR), the Principles for Responsible Investment (PRI) and the Access to Medicine Foundation will co-host an investor webinar about the Access to Vaccines Index, focusing on access to vaccines as a material issue for investors in pharmaceutical companies.

02 Nov 2016

Margot de Graaff from the UNICEF Netherlands magazine interviews Jayasree K Iyer and Suzanne Wolf regarding the pharmaceutical industry, the Access to Medicines Index and the upcoming Access to Vaccines Index.

How are vaccine companies responding to key global health challenges? Looking at how the first malaria and dengue vaccines are being deployed; and responses to emerging infectious diseases such as Ebola and Zika virus.

“Disease outbreaks will continue to occur.
Companies need to be at the table as governments and others work to build resilient health systems.”